Webinar Description:
This webinar will examine how biomarkers are used to define “PD-L1” positive patients around the globe and in resource limited settings. It will provide a forum for physicians to discuss their experience assessing different criteria, as well as the solutions that were implemented to overcome specific challenges. Additionally, this topic will review the global availability of different platforms/clones and tumor mutational burden (TMB).
Webinar Moderator:
Paolo Ascierto, MD – Instituto Nazionale Tumori IRCCS Fondazione G. Pascale
Webinar Faculty:
Jyoti Bajpai, MD, DM – Tata Memorial Center
Danny Khalil, MD, PhD – Memorial Sloan Kettering Cancer Center
Taha Merghoub, PhD – Weill Cornell Medicine